tradingkey.logo
tradingkey.logo
Buscar

Cytek Biosciences Inc

CTKB
Añadir a la lista de seguimiento
4.590USD
+0.010+0.22%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
590.05MCap. mercado
PérdidaP/E TTM

Más Datos de Cytek Biosciences Inc Compañía

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Información de Cytek Biosciences Inc

Símbolo de cotizaciónCTKB
Nombre de la empresaCytek Biosciences Inc
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoJiang (Wenbin)
Número de empleados648
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 23
Dirección47215 Lakeview Boulevard
CiudadFREMONT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94538
Teléfono18779229835
Sitio Webhttps://cytekbio.com
Símbolo de cotizaciónCTKB
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoJiang (Wenbin)

Ejecutivos de Cytek Biosciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
--
--
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Cytek Biosciences Inc?

Los cinco principales accionistas de Cytek Biosciences Inc son: Dr. Wenbin Jiang, Ph.D.

¿Cuántas instituciones poseen acciones de Cytek Biosciences Inc (CTKB)?

A fecha de 2026Q1, 335 instituciones poseen acciones de Cytek Biosciences Inc, con un valor de mercado combinado de aproximadamente 84.13M, lo que representa el 65.16% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -7060937.00.

¿Cuál es la mayor fuente de ganancias de Cytek Biosciences Inc?

El 2026Q1, el segmento empresarial Biotechnology, pharmaceutical, distributor and CRO generó la ganancia más alta para Cytek Biosciences Inc, ascendiendo a 116.73M y representando el 57.93% de la ganancia total.